"Perhaps my perspective is different from most, as in my mind, there was always a chance Pyrr could end up having an issue with Direct and DCVax-L. Data crunch folks don't like doubt, and riddled-data to crunch with inevitably means doubt. He can not support Direct, because he can not see the data. There's a chance he may not be able to support DCVax-L down the line either (assuming he one day comes to the determination that the data he thought he analyzed may have been riddled on him too)."
What a joke. When has Py ever been data driven. What he has always been is interpretation driven. If I were not so lazy, I would repost a dozen or so Py posts on Direct from last year leading up to ASCO that were so far off base, it made me run from this board. Py is a master at dreaming up interpretation of limited data when it suits his agenda. So, it does not suit his case now. Nobody should be surprised.
News 
Market Data 
Discover 
AI
